Main interest of the Unit is to unravel the key molecular and cellular mechanisms controlling immune tolerance, responsible for maintaining tissue homeostasis and
avoiding adverse immune responses.
The drug appears to have surmounted an important technical hurdle: so far it has not created
any adverse immune response in patients.
«This is particularly promising as these cells should be more readily obtainable than conventional neural stem cells and would not carry the risk of
an adverse immune response.»
«These findings suggest that those who age «well» demonstrate anti-inflammaging mechanisms (and biomarkers) that likely counteract
the adverse immune response of inflammaging.»